{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:29:04Z","timestamp":1791253744962,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ejim.2011.12.001","type":"journal-article","created":{"date-parts":[[2011,12,31]],"date-time":"2011-12-31T01:42:15Z","timestamp":1325295735000},"page":"197-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["The physiological significance and potential clinical applications of ghrelin"],"prefix":"10.1016","volume":"23","author":[{"given":"Takashi","family":"Akamizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kangawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2011.12.001_bb0005","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejim.2011.12.001_bb0010","first-page":"1738","article-title":"Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines","volume":"86","author":"Cassoni","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.12.001_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-2999(03)02083-1","article-title":"Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln(14)-ghrelin","volume":"476","author":"Bedendi","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/en.2003-0899","article-title":"Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor","volume":"145","author":"Thompson","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejim.2011.12.001_bb0025","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1210\/jc.2003-031964","article-title":"Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans","volume":"89","author":"Broglio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.12.001_bb0030","first-page":"881","article-title":"The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors","volume":"86","author":"Korbonits","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.12.001_bb0035","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1210\/endo.142.2.7987","article-title":"Ghrelin, a novel placental-derived hormone","volume":"142","author":"Gualillo","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejim.2011.12.001_bb0040","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1210\/jcem.87.6.8739","article-title":"The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans","volume":"87","author":"Gnanapavan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.12.001_bb0045","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/35038090","article-title":"Ghrelin induces adiposity in rodents","volume":"407","author":"Tschop","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejim.2011.12.001_bb0050","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1210\/endo.141.11.7873","article-title":"The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion","volume":"141","author":"Wren","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejim.2011.12.001_bb0055","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35051587","article-title":"A role for ghrelin in the central regulation of feeding","volume":"409","author":"Nakazato","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejim.2011.12.001_bb0060","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1210\/jcem.85.12.7167","article-title":"Ghrelin strongly stimulates growth hormone release in humans","volume":"85","author":"Takaya","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.12.001_bb0065","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/BF03343763","article-title":"Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans","volume":"23","author":"Arvat","year":"2000","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ejim.2011.12.001_bb0070","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1530\/eje.0.143r011","article-title":"Ghrelin-induced growth hormone secretion in humans","volume":"143","author":"Peino","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0075","doi-asserted-by":"crossref","first-page":"R1483","DOI":"10.1152\/ajpregu.2001.280.5.R1483","article-title":"Hemodynamic and hormonal effects of human ghrelin in healthy volunteers","volume":"280","author":"Nagaya","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0080","first-page":"1169","article-title":"Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone","volume":"86","author":"Arvat","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.12.001_bb0085","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1210\/jcem.86.9.8002","article-title":"A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans","volume":"86","author":"Hataya","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.12.001_bb0090","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1210\/jcem.86.12.8111","article-title":"Ghrelin enhances appetite and increases food intake in humans","volume":"86","author":"Wren","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.12.001_bb0095","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pharmthera.2008.02.008","article-title":"Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis","volume":"118","author":"Dezaki","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ejim.2011.12.001_bb0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1043-2760(98)00116-7","article-title":"Growth hormone secretagogues: physiological role and clinical utility","volume":"10","author":"Casanueva","year":"1999","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.12.001_bb0105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/07853899808999399","article-title":"Orally active growth hormone secretagogues: state of the art and clinical perspectives","volume":"30","author":"Ghigo","year":"1998","journal-title":"Ann Med"},{"issue":"Suppl 3","key":"10.1016\/j.ejim.2011.12.001_bb0110","first-page":"56","article-title":"Growth hormone secretagogues and ghrelin: an update on physiology and clinical relevance","volume":"58","author":"Petersenn","year":"2002","journal-title":"Horm Res"},{"key":"10.1016\/j.ejim.2011.12.001_bb0115","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1210\/jc.2003-031768","article-title":"Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial","volume":"89","author":"Neary","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.12.001_bb0120","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-07-0768","article-title":"Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite","volume":"158","author":"Akamizu","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0125","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.bjc.6604148","article-title":"Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia\/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study","volume":"98","author":"Strasser","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejim.2011.12.001_bb0130","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1507\/endocrj.K09E-168","article-title":"Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study","volume":"56","author":"Hotta","year":"2009","journal-title":"Endocr J"},{"key":"10.1016\/j.ejim.2011.12.001_bb0135","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1161\/01.CIR.0000149746.62908.BB","article-title":"Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure","volume":"110","author":"Nagaya","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2011.12.001_bb0140","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1378\/chest.128.3.1187","article-title":"Treatment of cachexia with ghrelin in patients with COPD","volume":"128","author":"Nagaya","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2011.12.001_bb0145","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1210\/en.2007-0828","article-title":"Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia","volume":"149","author":"Garcia","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejim.2011.12.001_bb0150","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1681\/ASN.2005010039","article-title":"Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial","volume":"16","author":"Wynne","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0155","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1111\/j.1532-5415.2008.02031.x","article-title":"Effects of ghrelin treatment on patients undergoing total hip replacement for osteoarthritis: different outcomes from studies in patients with cardiac and pulmonary cachexia","volume":"56","author":"Akamizu","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ejim.2011.12.001_bb0160","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1053\/j.gastro.2009.12.058","article-title":"Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study","volume":"138","author":"Adachi","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.12.001_bb0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.surg.2009.11.026","article-title":"Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction","volume":"148","author":"Yamamoto","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.ejim.2011.12.001_bb0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.physbeh.2006.05.022","article-title":"Ghrelin and the short- and long-term regulation of appetite and body weight","volume":"89","author":"Cummings","year":"2006","journal-title":"Physiol Behav"},{"key":"10.1016\/j.ejim.2011.12.001_bb0175","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1053\/j.gastro.2007.03.048","article-title":"Gut hormones and appetite control","volume":"132","author":"Wren","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.12.001_bb0180","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1210\/en.2003-1596","article-title":"Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein","volume":"145","author":"Chen","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejim.2011.12.001_bb0185","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.2337\/diabetes.50.11.2438","article-title":"Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats","volume":"50","author":"Kamegai","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ejim.2011.12.001_bb0190","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2337\/diabetes.50.2.227","article-title":"Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y\/Y1 receptor pathway","volume":"50","author":"Shintani","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ejim.2011.12.001_bb0195","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1210\/en.2002-220788","article-title":"Ghrelin-induced food intake is mediated via the orexin pathway","volume":"144","author":"Toshinai","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejim.2011.12.001_bb0200","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1053\/gast.2002.35954","article-title":"The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats","volume":"123","author":"Date","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.12.001_bb0205","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.2337\/diabetes.50.11.2540","article-title":"Ghrelin causes hyperphagia and obesity in rats","volume":"50","author":"Wren","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ejim.2011.12.001_bb0210","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/eje.0.1500447","article-title":"Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects","volume":"150","author":"Akamizu","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0215","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/0003-4819-149-9-200811040-00003","article-title":"Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial","volume":"149","author":"Nass","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2011.12.001_bb0220","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1210\/jc.2007-2234","article-title":"Evidence for acyl\u2013ghrelin modulation of growth hormone release in the fed state","volume":"93","author":"Nass","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.12.001_bb0225","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1210\/er.2006-0052","article-title":"The growth hormone\/insulin-like growth factor-I axis in exercise and sport","volume":"28","author":"Gibney","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejim.2011.12.001_bb0230","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/bjp.2008.153","article-title":"Regulation of muscle mass by growth hormone and IGF-I","volume":"154","author":"Velloso","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0235","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1172\/JCI200421134","article-title":"Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells","volume":"114","author":"Dixit","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2011.12.001_bb0240","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1161\/01.CIR.0000127956.43874.F2","article-title":"Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells","volume":"109","author":"Li","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2011.12.001_bb0245","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1053\/j.gastro.2006.01.041","article-title":"Therapeutic action of ghrelin in a mouse model of colitis","volume":"130","author":"Gonzalez-Rey","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.12.001_bb0250","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1164\/rccm.200604-511OC","article-title":"Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats","volume":"176","author":"Wu","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2011.12.001_bb0255","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.4049\/jimmunol.0803362","article-title":"Suppression of experimental autoimmune encephalomyelitis by ghrelin","volume":"183","author":"Theil","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0260","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.pupt.2008.05.001","article-title":"Ghrelin treatment suppresses neutrophil-dominant inflammation in airways of patients with chronic respiratory infection","volume":"21","author":"Kodama","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.ejim.2011.12.001_bb0265","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.surg.2007.09.039","article-title":"Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways","volume":"143","author":"Waseem","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.ejim.2011.12.001_bb0270","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI30555","article-title":"Physiology and immunology of the cholinergic antiinflammatory pathway","volume":"117","author":"Tracey","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2011.12.001_bb0275","doi-asserted-by":"crossref","first-page":"C834","DOI":"10.1152\/ajpcell.00579.2003","article-title":"The molecular basis of skeletal muscle atrophy","volume":"287","author":"Jackman","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0280","doi-asserted-by":"crossref","first-page":"R893","DOI":"10.1152\/ajpregu.00015.2008","article-title":"Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases MuRF1 and MAFbx","volume":"296","author":"Balasubramaniam","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0285","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.peptides.2009.06.029","article-title":"Ghrelin receptor agonist, GHRP-2, attenuates burn injury-induced MuRF-1 and MAFbx expression and muscle proteolysis in rats","volume":"30","author":"Sheriff","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.ejim.2011.12.001_bb0290","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.lfs.2007.11.019","article-title":"GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin ligases, Atrogin-1 and MuRF1","volume":"82","author":"Yamamoto","year":"2008","journal-title":"Life Sci"},{"key":"10.1016\/j.ejim.2011.12.001_bb0295","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","article-title":"The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors","volume":"14","author":"Stitt","year":"2004","journal-title":"Mol Cell"},{"issue":"Suppl 4","key":"10.1016\/j.ejim.2011.12.001_bb0300","first-page":"95","article-title":"Central and peripheral mechanisms by which ghrelin regulates gut motility","volume":"54","author":"Peeters","year":"2003","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0305","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1210\/en.2002-220756","article-title":"Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action","volume":"144","author":"Sibilia","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejim.2011.12.001_bb0310","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1210\/en.2008-0255","article-title":"Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation","volume":"149","author":"Xu","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejim.2011.12.001_bb0315","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.nut.2008.06.020","article-title":"Cachexia and neuropeptide Y","volume":"24","author":"Morley","year":"2008","journal-title":"Nutrition"},{"key":"10.1016\/j.ejim.2011.12.001_bb0320","first-page":"41","article-title":"Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves","volume":"60","author":"Konturek","year":"2009","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0325","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jcem.86.10.7885","article-title":"Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans","volume":"86","author":"Ariyasu","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.12.001_bb0330","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/eje.0.149r001","article-title":"Plasma levels of active form of ghrelin during oral glucose tolerance test in patients with anorexia nervosa","volume":"149","author":"Nakai","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0335","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1210\/jc.2004-0353","article-title":"Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa","volume":"89","author":"Hotta","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.12.001_bb0340","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1210\/jc.2005-2304","article-title":"Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa","volume":"91","author":"Miljic","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.12.001_bb0345","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1365-2265.2004.02011.x","article-title":"The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state","volume":"60","author":"Broglio","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejim.2011.12.001_bb0350","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1992"},{"issue":"Suppl 2","key":"10.1016\/j.ejim.2011.12.001_bb0355","first-page":"II37","article-title":"Functional gastroduodenal disorders","volume":"45","author":"Talley","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2011.12.001_bb0360","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1080\/00365520510015403","article-title":"Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patients","volume":"40","author":"Shinomiya","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0365","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.peptides.2011.05.018","article-title":"Therapeutic applications of ghrelin to cachexia utilizing its appetite-stimulating effect","volume":"32","author":"Akamizu","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.ejim.2011.12.001_bb0370","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ajcn\/83.4.735","article-title":"Cachexia: pathophysiology and clinical relevance","volume":"83","author":"Morley","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ejim.2011.12.001_bb0375","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1389450053174569","article-title":"Ghrelin and energy balance: focus on current controversies","volume":"6","author":"Cummings","year":"2005","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.ejim.2011.12.001_bb0380","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00003495-200666040-00004","article-title":"Therapeutic potential of ghrelin in the treatment of heart failure","volume":"66","author":"Nagaya","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.ejim.2011.12.001_bb0385","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF02696650","article-title":"Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches","volume":"2","author":"Akashi","year":"2005","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.ejim.2011.12.001_bb0390","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2169\/internalmedicine.45.1402","article-title":"Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia","volume":"45","author":"Nagaya","year":"2006","journal-title":"Intern Med"},{"key":"10.1016\/j.ejim.2011.12.001_bb0395","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2169\/internalmedicine.45.1867","article-title":"Ghrelin and neurohumoral antagonists in the treatment of cachexia associated with cardiopulmonary disease","volume":"45","author":"Lainscak","year":"2006","journal-title":"Intern Med"},{"key":"10.1016\/j.ejim.2011.12.001_bb0400","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.peptides.2009.07.002","article-title":"Ghrelin and its therapeutic potential for cachectic patients","volume":"30","author":"Ashitani","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.ejim.2011.12.001_bb0405","series-title":"The 5th cachexia conference, Barcelona","first-page":"143","article-title":"Performance improvement in COPD cachexia with SUN11031 (a synthetic human ghrelin) in a placebo controlled trial [abstract]","author":"Gertner","year":"2009"},{"key":"10.1016\/j.ejim.2011.12.001_bb0410","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1210\/en.2007-0016","article-title":"Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia","volume":"148","author":"DeBoer","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejim.2011.12.001_bb0415","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0006-291X(02)03028-0","article-title":"Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells","volume":"301","author":"Hanada","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejim.2011.12.001_bb0420","first-page":"1393","article-title":"Effects of ghrelin on anorexia in tumor-bearing mice with eicosanoid-related cachexia","volume":"28","author":"Wang","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0425","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1200\/jco.2007.25.18_suppl.9133","article-title":"A Phase II, randomized, placebo-controlled, double blind study of the efficacy and safety of RC-1291 for the treatment of cancer-cachexia [abstract]","volume":"25","author":"Garcia","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0430","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.ki.5001572","article-title":"Anorexia in hemodialysis patients: an update","volume":"70","author":"Bossola","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2011.12.001_bb0435","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ki.2009.114","article-title":"Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment","volume":"76","author":"Ashby","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2011.12.001_bb0440","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/en.2007-1046","article-title":"Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile","volume":"149","author":"Deboer","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejim.2011.12.001_bb0445","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/edrv-14-1-20","article-title":"Human growth hormone and human aging","volume":"14","author":"Corpas","year":"1993","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejim.2011.12.001_bb0450","doi-asserted-by":"crossref","first-page":"B174","DOI":"10.1093\/geronj\/43.6.B174","article-title":"Calorie and nutrient intakes of elderly and young subjects measured under identical conditions","volume":"43","author":"Wurtman","year":"1988","journal-title":"J Gerontol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0455","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/ajcn\/66.4.760","article-title":"Anorexia of aging: physiologic and pathologic","volume":"66","author":"Morley","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ejim.2011.12.001_bb0460","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1152\/physrev.1999.79.2.511","article-title":"Neuroendocrine control of growth hormone secretion","volume":"79","author":"Muller","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ejim.2011.12.001_bb0465","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1530\/eje.0.1430585","article-title":"Use of human GH in elderly patients with accidental hip fracture","volume":"143","author":"Van der Lely","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0470","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2265.2003.01700.x","article-title":"Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement","volume":"58","author":"Weissberger","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejim.2011.12.001_bb0475","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ghir.2003.08.001","article-title":"Frailty and the biochemical effects of recombinant human growth hormone in women after surgery for hip fracture","volume":"13","author":"Yeo","year":"2003","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.ejim.2011.12.001_bb0480","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1532-5415.2004.52156.x","article-title":"The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture","volume":"52","author":"Bach","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ejim.2011.12.001_bb0485","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1677\/joe.1.06442","article-title":"Plasma ghrelin levels in healthy elderly volunteers: the levels of acylated ghrelin in elderly females correlate positively with serum IGF-I levels and bowel movement frequency and negatively with systolic blood pressure","volume":"188","author":"Akamizu","year":"2006","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ejim.2011.12.001_bb0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jss.2005.08.003","article-title":"Postoperative ghrelin levels and delayed recovery from body weight loss after distal or total gastrectomy","volume":"130","author":"Takachi","year":"2006","journal-title":"J Surg Res"},{"key":"10.1016\/j.ejim.2011.12.001_bb0495","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.surg.2005.11.015","article-title":"Ghrelin reduction after esophageal substitution and its correlation to postoperative body weight loss in esophageal cancer patients","volume":"139","author":"Doki","year":"2006","journal-title":"Surgery"},{"key":"10.1016\/j.ejim.2011.12.001_bb0500","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1507\/endocrj.KR-79","article-title":"Translational research on the clinical applications of ghrelin","volume":"53","author":"Akamizu","year":"2006","journal-title":"Endocr J"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511003086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511003086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:27:00Z","timestamp":1760606820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620511003086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0953620511003086"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2011.12.001","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The physiological significance and potential clinical applications of ghrelin","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2011.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}